Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy

Diabetic retinopathy (DR) is a microvascular disease caused by poorly controlled blood glucose, and it is a leading cause of vision loss in people with diabetes. In this review we discuss the current management of DR with particular focus on the use of intraocular anti-vascular endothelial growth fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahr, Tyler A., Bakri, Sophie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222751/
https://www.ncbi.nlm.nih.gov/pubmed/37240743
http://dx.doi.org/10.3390/life13051098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222751/
https://www.ncbi.nlm.nih.gov/pubmed/37240743
http://dx.doi.org/10.3390/life13051098

Ejemplares similares